KIF4A Promotes Clear Cell Renal Cell Carcinoma (ccRCC) Proliferation in Vitro and in Vivo

Overview

Journal Onco Targets Ther

Publisher Dove Medical Press

Specialty Oncology

Date 2020 Apr 14

PMID 32280241

Citations 3

Authors

Guang-Hua Yang

Zhi-Xing Ren

Xiong Yang

Yan-Gang Zhang

Affiliations

Soon will be listed here.

Abstract

Purpose: To evaluate the expression in human clear cell renal cell carcinoma (ccRCC) tissues and explore the effects of kinesin family member 4A (KIF4A) on ccRCC progression.

Methods: GEPIA was used to evaluate the mRNA levels of KIF4A in human ccRCC tissues from TCGA database, and Immunohistochemistry (IHC) assays were performed to assess its expression in human ccRCC tissues collected in our hospital. The clinical-pathological analysis was performed to explore the correlation with KIF4A expression. The effects of KIF4A on ccRCC cell proliferation were detected through colony formation and MTT assays. Finally, the effects of KIF4A on tumor growth were measured using a mice model.

Results: Bioinformation results showed the expression of KIF4A mRNA was upregulated in ccRCC tissues and high expression of KIF4A was related with poor prognosis in ccRCC patients. We also found a high expression of KIF4A in human ccRCC tissues collected in our hospital. We also found its expression level was correlated with clinical characteristics, including T stage (P=0.035*) and lymphatic metastasis (P=0.028*). We further confirmed that knockdown of KIF4A suppressed cell proliferation in HTB-47 and CRL-1932 cells. Furthermore, KIF4A contributes to tumor growth of ccRCC cells in mice.

Conclusion: We found the abnormal high expression of KIF4A in human ccRCC tissues and demonstrated that KIF4A could serve as a tumor induction gene.

Citing Articles

ERCC6L facilitates the progression of laryngeal squamous cell carcinoma by the binding of FOXM1 and KIF4A.

Cui M, Chang Y, Wang J, Wu J, Li G, Tan J Cell Death Discov. 2023; 9(1):41.

PMID: 36726012 PMC: 9892579. DOI: 10.1038/s41420-023-01314-3.

Study on the expression of TOP2A in hepatocellular carcinoma and its relationship with patient prognosis.

Meng J, Wei Y, Deng Q, Li L, Li X Cancer Cell Int. 2022; 22(1):29.

PMID: 35033076 PMC: 8761301. DOI: 10.1186/s12935-021-02439-0.

Let-7i-5p enhances cell proliferation, migration and invasion of ccRCC by targeting HABP4.

Liu Y, Hu X, Hu L, Xu C, Liang X BMC Urol. 2021; 21(1):49.

PMID: 33775245 PMC: 8005230. DOI: 10.1186/s12894-021-00820-9.

References

Bie L, Zhao G, Cheng P, Rondeau G, Porwollik S, Ju Y . The accuracy of survival time prediction for patients with glioma is improved by measuring mitotic spindle checkpoint gene expression. PLoS One. 2011; 6(10):e25631. PMC: 3192043. DOI: 10.1371/journal.pone.0025631. View

Wong K, Liu J, Chan K . KIF7 attenuates prostate tumor growth through LKB1-mediated AKT inhibition. Oncotarget. 2017; 8(33):54558-54571. PMC: 5589603. DOI: 10.18632/oncotarget.17421. View

Wan Q, Shen Y, Zhao H, Wang B, Zhao L, Zhang Y . Impaired DNA double-strand breaks repair by kinesin family member 4A inhibition renders human H1299 non-small-cell lung cancer cells sensitive to cisplatin. J Cell Physiol. 2018; 234(7):10360-10371. DOI: 10.1002/jcp.27703. View

Ghatalia P, Zibelman M, Geynisman D, Plimack E . Evolving landscape of the treatment of metastatic clear cell renal cell carcinoma. Clin Adv Hematol Oncol. 2018; 16(10):677-686. View

Grande Pulido E, Martin Centeno A, Maroto Rey P, Narbon E . [Molecular biology of the clear cell renal cell carcinoma: principles for a selective treatment]. Actas Urol Esp. 2007; 31(3):233-43. DOI: 10.1016/s0210-4806(07)73628-8. View

Kurasawa Y, Earnshaw W, Mochizuki Y, Dohmae N, Todokoro K . Essential roles of KIF4 and its binding partner PRC1 in organized central spindle midzone formation. EMBO J. 2004; 23(16):3237-48. PMC: 514520. DOI: 10.1038/sj.emboj.7600347. View

Rath O, Kozielski F . Kinesins and cancer. Nat Rev Cancer. 2012; 12(8):527-39. DOI: 10.1038/nrc3310. View

Camlin N, McLaughlin E, Holt J . Motoring through: the role of kinesin superfamily proteins in female meiosis. Hum Reprod Update. 2017; 23(4):409-420. DOI: 10.1093/humupd/dmx010. View

Sheng L, Hao S, Yang W, Sun Y . The multiple functions of kinesin-4 family motor protein KIF4 and its clinical potential. Gene. 2018; 678:90-99. DOI: 10.1016/j.gene.2018.08.005. View

10.

Bastos R, Cundell M, Barr F . KIF4A and PP2A-B56 form a spatially restricted feedback loop opposing Aurora B at the anaphase central spindle. J Cell Biol. 2014; 207(6):683-93. PMC: 4274259. DOI: 10.1083/jcb.201409129. View

11.

Tostain J, Li G, Gentil-Perret A, Gigante M . Carbonic anhydrase 9 in clear cell renal cell carcinoma: a marker for diagnosis, prognosis and treatment. Eur J Cancer. 2010; 46(18):3141-8. DOI: 10.1016/j.ejca.2010.07.020. View

12.

Fu X, Zhu Y, Zheng B, Zou Y, Wang C, Wu P . KIFC1, a novel potential prognostic factor and therapeutic target in hepatocellular carcinoma. Int J Oncol. 2018; 52(6):1912-1922. PMC: 5919720. DOI: 10.3892/ijo.2018.4348. View

13.

Gao J, Sai N, Wang C, Sheng X, Shao Q, Zhou C . Overexpression of chromokinesin KIF4 inhibits proliferation of human gastric carcinoma cells both in vitro and in vivo. Tumour Biol. 2010; 32(1):53-61. DOI: 10.1007/s13277-010-0090-0. View

14.

Bastos R, Gandhi S, Baron R, Gruneberg U, Nigg E, Barr F . Aurora B suppresses microtubule dynamics and limits central spindle size by locally activating KIF4A. J Cell Biol. 2013; 202(4):605-21. PMC: 3747307. DOI: 10.1083/jcb.201301094. View

15.

Wu G, Chen P . Structural requirements of chromokinesin Kif4A for its proper function in mitosis. Biochem Biophys Res Commun. 2008; 372(3):454-8. DOI: 10.1016/j.bbrc.2008.05.065. View

16.

Minakawa Y, Kasamatsu A, Koike H, Higo M, Nakashima D, Kouzu Y . Kinesin family member 4A: a potential predictor for progression of human oral cancer. PLoS One. 2014; 8(12):e85951. PMC: 3875575. DOI: 10.1371/journal.pone.0085951. View

17.

Willemsen M, Ba W, Wissink-Lindhout W, de Brouwer A, Haas S, Bienek M . Involvement of the kinesin family members KIF4A and KIF5C in intellectual disability and synaptic function. J Med Genet. 2014; 51(7):487-94. DOI: 10.1136/jmedgenet-2013-102182. View

18.

Hogner A, Krause H, Jandrig B, Kasim M, Fuller T, Schostak M . PBRM1 and VHL expression correlate in human clear cell renal cell carcinoma with differential association with patient's overall survival. Urol Oncol. 2017; 36(3):94.e1-94.e14. DOI: 10.1016/j.urolonc.2017.10.027. View

19.

Alsharedi M, Katz H . Check point inhibitors a new era in renal cell carcinoma treatment. Med Oncol. 2018; 35(6):85. DOI: 10.1007/s12032-018-1147-y. View

20.

Wang X, Wang T, Chen C, Wu Z, Bai P, Li S . Serum exosomal miR-210 as a potential biomarker for clear cell renal cell carcinoma. J Cell Biochem. 2018; 120(2):1492-1502. DOI: 10.1002/jcb.27347. View